Long Term Use Of Fosamax and Boniva Causes Thigh Bone Fractures, Tennessee Patient Charges in Lawsuit
Reba Inez Patton of Tennessee spoke about her atypical femur fracture, which may have been caused by Fosamax and Boniva osteoprosis drugs: “When I walk, it is scary because I do not want to fall again. I just want to walk without a cane again and I want to be sure that leg will hold me without a cane.”
Patton and her entire family have suffered from the Fosamax and Boniva prescriptions she has taken since 2001. Patton took Fosamax from 2001 to 2006, and took Boniva from 2006 to 2010. Doctors prescribed Fosamax and Boniva, both bisphosphonate drugs, to slow bone loss and combat Patton’s osteoporosis.
However, long term use of these drugs has actually been found to cause brittle bones and to increase the risk of atypical bone fractures. On December 10, 2010, Patton suffered a subtrochanteric femoral fracture while walking up steps. This aptypical femur fracture has been devasting for Patton and her family. Patton noted, “My husband now does a lot of the work I used to do. The accident changed a good part of my life; it put a lot of extra burden on my family.”
Lieff Cabraser attorney Kent Klaudt announced that Reba Patton and her husband Patrick Patton have filed a lawsuit against Fosamax manufacturer Merck&Co., and against Boniva manufacturer GlaxoSmithKine, LLC. Klaudt said, “Merck and GlaxoSmithKline, as alleged in the complaint, concealed and continue to conceal their knowledge of bisphosphonates’ lack of long-term benefits and dangers to Mrs. Patton and other patients.”
To learn more about Fosamax, Boniva and other bisphosphonate drugs, as well as victims’ rights, visit our Bone Drugs and Femur Fractures information page.
Related posts:
